499 Myeloid diversity in hormone receptor positive breast cancer reveals myeloid and lymphoid signaling pathways that correlate with T cell inhibition

• Jennifer L Guerriero,
• Madeline G Townsend,
• Daniel E Michaud,
• Kenichi Shimada,
• Chenyi Gu,
• Lukas Kania

Affiliations

Jennifer L Guerriero

1Brigham and Women’s Hospital, Boston, MA, USA

Madeline G Townsend

4Brigham and Women’s Hospital, Brookline, MA, USA

Daniel E Michaud

1Brigham and Women’s Hospital, Boston, MA, USA

Kenichi Shimada

2Harvard Medical School, Boston, MA, USA

Chenyi Gu

1Division of Breast Surgery, Department of Surgery, Brigham and Women’s Hospital, Boston, MA, USA

Lukas Kania

1Division of Breast Surgery, Department of Surgery, Brigham and Women’s Hospital, Boston, MA, USA